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Background
Haas first described what is now acknowledged as being X linked retinoschisis (XLRS) nearly a century ago in a paper entitled 'Ueber das Zusammenvorkommen von Veranderungen der Retina und Choroidea'. I Accompanying his description of the disease in two males was a beautiful drawing of the typical radiating cystic maculopathy. The fact that subsequent authors failed to observe these macular changes and instead described the peripheral retinal features of the disease2-4 is testimony perhaps to his shrewd powers of observation. Although Haas believed the retinal and choroidal changes were inflammatory in origin, Pagenstecher published a pedigree some 15 years later which showed an X linked pattern of inheritance.5 The variable clinical manifestations of the disease are exemplified by the wide variety of names that have been ascribed to XLRS in the past. 'Anterior retinal dialysis',6 'neuroretinal disease in males',7 'congenital cystic detachment of the retina',2 and 'congenital vascular veils'8 were variously used to describe the condition before Jager coined the term X linked retinoschisis.9 There are no other systemic associations and experience does not support Jager's assertion that all affected patients were 'from their early youth very difficult and extremely irritable persons'! Clinical features XLRS has been described worldwide in white,'0 black," I 12 and Asian people.'3 Although considered a rare condition it is much underdiagnosed and is among the commonest causes of juvenile macular degeneration.'0 The largest series of patients has been described in Finland where XLRS had a carrier prevalence of 14 per 10 000 population'4 and it was considered to be the commonest X linked condition in that country before the increased recognition of fragile X syndrome. ' Peripheral retinoschisis is present in around 50% of patients.10 22 The splitting occurs in the superficial layers of the retina and as such retinal vessels may lie in either the outer or inner leaf or cross from one to the other through the schisis cavity. The inner leaf ofthe schisis tends to fragment with time leaving large inner leaf breaks (Fig 3) and membranous remnants on the posterior hyaloid face, so called vitreous veils28 29 (Fig 4) . Often Studies using intraretinal microelectrodes in the mudpuppy have demonstrated that the Muller cell has a similar intensity-response curve to the b-wave of the ERG. 64 Other components of the ERG that are known to arise from inner or middle retina are affected in XLRS: both the cone and rod oscillatory potentials (OPs) and the scotopic threshold response (STR) -a small electronegative response that is produced at stimuli so dim that the scotopic b-wave is not evident -are absent. 58 65 There is wide disparity between the reduction in electrophysiological and psychophysical responses: while the STR and b-wave may be profoundly reduced, absolute thresholds58 65 and dark adaptation curves1°66 are normal or only minimally elevated.
The psychophysical determination of rod-cone interaction has been of interest in identifying the site of the abnormality in XLRS. In normal individuals, the ability of cones to perceive flicker deteriorates as rods dark adapt. 67 Conversely, when dark adapted rods are exposed to dim light this function improves. This normal suppressive rodcone interaction is thought to be mediated by postsynaptic feedback onto cones via horizontal cells and may be absent in some affected males66 68 
patients who had XLRS and a tapetal reflex. A similar change in retinal colour had been shown on leakage of potassium ions from a microelectrode in the cat and monkey retina. In the normal situation light exposure results in hyperpolarisation of the photoreceptors and an increase in extracellular potassium ions, whereas in the dark adapted state the photoreceptors depolarise and the extracellular potassium ion concentration is lower.76 The Muller cell transports the potassium ions from the outer retina into the vitreous cavity via its endfoot processes.77 In XLRS the inability of defective Miiller cells to mop up the increased extracellular potassium ions on exposure to light could account for the tapetal reflex and Mizuo phenomenon observed in this disease. 33 Other theories of pathophysiology have been proposed. Ewing et al postulated a vascular theory to the development of XLRS, based upon choroidal filling defects and slowing of the retinal circulation demonstrated by fluorescein angiography in some patients.78 They proposed that the retinoschisis resulted from delayed development of the retinal and choroidal vasculature in which the retina outgrows its blood supply inferotemporally. The demonstration of capillary dropout in schitic as well as non-schitic areas of the retina has also supported this theory,79 but it would not explain the presence of foveal schisis. Schepens believed that the vitreous plays an important role on the basis that peripheral retinoschisis tended to flatten following vitreous detachment.38 It 
Molecular genetics
The locus for XLRS has been localised to the Xp22 region of the distal short arm of the X chromosome with no evidence of genetic heterogeneity.'5 17 85-88 A multitude of highly polymorphic microsatellite markers has recently become available in this region.89-92 These dinucleotide repeat sequences show great variation in length within the general population, which makes them ideal for tracking the disease gene for the purposes of carrier detection or gene mapping. They have the added advantage that they can be used with the polymerase chain reaction (PCR), so that small amounts of DNA can be amplified rapidly for analysis. Key recombination events in two British pedigrees have localised the gene for XLRS to a 2-3 cM region flanked by the microsatellite markers (DXS207, DXS 1053) distally and DXS999 proximally. 93 Polymorphic markers, which lie close to and flank the proximal and distal sides of the XLRS locus, now exist which can be used for carrier detection. The improved localisation of the gene means that positional cloning and characterisation of the XLRS gene should be feasible in the near future.
Management and prognosis
There is no known cure for XLRS but correct and early diagnosis is important for accurate prognosis, genetic counselling, and facilitating educational requirements in a child with visual handicap. Strabismus, refractive errors, and amblyopia should be corrected to maximise visual potential. Attempts to flatten peripheral retinoschisis by treating the outer leaf with laser photocoagulation have led to a high incidence of retinal detachment,22 41 94 but panretinal photocoagulation has been used successfully to treat disc and peripheral new vessels.3' 32 Vitreous haemorrhage usually clears spontaneously, although vitrectomy may be required to reduce the risk of amblyopia in young children if the haemorrhage is particularly dense or persistent.39 Variable success rates have been reported following scleral buckling for retinal detachment22 39 and vitrectomy with internal tamponade offers the best outcome.39 95 In one case internal tamponade of an outer leaf break was facilitated by the removal of the whole of the inner leaf of the schisis cavity without deleterious effect. 39 Young patients affected by XLRS show moderate visual impairment.96 Visual acuity is usually in the 6/12 to 6/24 range'4 22 and some patients have been reported with normal acuity.'0 The disease is probably slowly progressivel' 14 but others report stable vision in uncomplicated cases.22 84 Most patients, however, retain reasonable vision until their fifth or sixth decades when some deterioration does occur due to macular atrophy.
Total blindness is an exception,'0 although Forsius reported that all patients over 70 years of age had a visual acuity of less than 6/60. 14 Future At present the underlying molecular defect in XLRS is unknown. However, steady progress in mapping the Xp22 region should lead to the cloning and characterisation of the gene for XLRS. This would permit reliable carrier detection and will also enhance our understanding of the role of the Muller cell in the pathology of XLRS leading to possible therapies in the future.
